These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 39137594)
21. Lymph Node Metastasis in Patients With Endometrioid Endometrial Cancer: Overtreatment Is the Main Issue. Karalok A; Turan T; Basaran D; Turkmen O; Comert Kimyon G; Tulunay G; Tasci T Int J Gynecol Cancer; 2017 May; 27(4):748-753. PubMed ID: 28301338 [TBL] [Abstract][Full Text] [Related]
22. Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion. Zahl Eriksson AG; Ducie J; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Abu-Rustum NR; Mariani A; Leitao MM Gynecol Oncol; 2016 Mar; 140(3):394-9. PubMed ID: 26747778 [TBL] [Abstract][Full Text] [Related]
23. Preoperative MRI and intraoperative frozen section diagnosis of myometrial invasion in patients with endometrial cancer. Tanaka T; Terai Y; Ono YJ; Fujiwara S; Tanaka Y; Sasaki H; Tsunetoh S; Kanemura M; Yamamoto K; Yamada T; Ohmichi M Int J Gynecol Cancer; 2015 Jun; 25(5):879-83. PubMed ID: 25950131 [TBL] [Abstract][Full Text] [Related]
24. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases]. Ma SK; Zhang HT; Sun YC; Wu LY Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912 [TBL] [Abstract][Full Text] [Related]
25. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Todo Y; Kato H; Kaneuchi M; Watari H; Takeda M; Sakuragi N Lancet; 2010 Apr; 375(9721):1165-72. PubMed ID: 20188410 [TBL] [Abstract][Full Text] [Related]
26. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma. Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408 [TBL] [Abstract][Full Text] [Related]
27. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573 [TBL] [Abstract][Full Text] [Related]
28. Factors related to recurrence in non-obese women with endometrial endometrioid adenocarcinoma. Panggid K; Cheewakriangkrai C; Khunamornpong S; Siriaunkgul S J Obstet Gynaecol Res; 2010 Oct; 36(5):1044-8. PubMed ID: 21058438 [TBL] [Abstract][Full Text] [Related]
29. Is lymphadenectomy a prognostic marker in endometrioid adenocarcinoma of the human endometrium? Bassarak N; Blankenstein T; Brüning A; Dian D; Bergauer F; Friese K; Mylonas I BMC Cancer; 2010 May; 10():224. PubMed ID: 20492712 [TBL] [Abstract][Full Text] [Related]
30. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy. Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094 [TBL] [Abstract][Full Text] [Related]
31. Does tumor size have prognostic value in patients undergoing lymphadenectomy in endometrioid-type endometrial cancer confined to the uterine corpus? Çakır C; Kılıç İÇ; Yüksel D; Karyal YA; Üreyen I; Boyraz G; Durmuş Y; Gültekin M; Özgül N; Karalök MA; Salman MC; Yüce K; Turan AT Turk J Med Sci; 2019 Oct; 49(5):1403-1410. PubMed ID: 31650820 [TBL] [Abstract][Full Text] [Related]
32. Impact of lymphadenectomy in uterine endometrioid carcinoma. Huang CY; Ho CM; Chen YL; You SL; Chen CA; Cheng WF Eur J Surg Oncol; 2013 Apr; 39(4):350-7. PubMed ID: 23462243 [TBL] [Abstract][Full Text] [Related]
33. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial. de Boer SM; Powell ME; Mileshkin L; Katsaros D; Bessette P; Haie-Meder C; Ottevanger PB; Ledermann JA; Khaw P; Colombo A; Fyles A; Baron MH; Jürgenliemk-Schulz IM; Kitchener HC; Nijman HW; Wilson G; Brooks S; Carinelli S; Provencher D; Hanzen C; Lutgens LCHW; Smit VTHBM; Singh N; Do V; D'Amico R; Nout RA; Feeney A; Verhoeven-Adema KW; Putter H; Creutzberg CL; Lancet Oncol; 2018 Mar; 19(3):295-309. PubMed ID: 29449189 [TBL] [Abstract][Full Text] [Related]
34. Oncologic outcomes of endometrial cancer in patients with low-volume metastasis in the sentinel lymph nodes: An international multi-institutional study. Ghoniem K; Larish AM; Dinoi G; Zhou XC; Alhilli M; Wallace S; Wohlmuth C; Baiocchi G; Tokgozoglu N; Raspagliesi F; Buda A; Zanagnolo V; Zapardiel I; Jagasia N; Giuntoli R; Glickman A; Peiretti M; Lanner M; Chacon E; Di Guilmi J; Pereira A; Laas E; Fishman A; Nitschmann CC; Parker S; Joehlin-Price A; Lees B; Covens A; De Brot L; Taskiran C; Bogani G; Paniga C; Multinu F; Hernandez-Gutierrez A; Weaver AL; McGree ME; Mariani A Gynecol Oncol; 2021 Sep; 162(3):590-598. PubMed ID: 34274133 [TBL] [Abstract][Full Text] [Related]
35. Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy? Beavis AL; Yen TT; Stone RL; Wethington SL; Carr C; Son J; Chambers L; Michener CM; Ricci S; Burkett WC; Richardson DL; Staley AS; Ahn S; Gehrig PA; Torres D; Dowdy SC; Sullivan MW; Modesitt SC; Watson C; Veade A; Ehrisman J; Havrilesky L; Secord AA; Loreen A; Griffin K; Jackson A; Viswanathan AN; Jager LR; Fader AN Gynecol Oncol; 2020 Mar; 156(3):568-574. PubMed ID: 31948730 [TBL] [Abstract][Full Text] [Related]
36. Lymphadenectomy in Early-Stage Intermediate-/High-Risk Endometrioid Endometrial Cancer: Clinical Characteristics and Outcomes in an Australian Cohort. Farrell R; Dixon SC; Carter J; Webb PM Int J Gynecol Cancer; 2017 Sep; 27(7):1379-1386. PubMed ID: 30814240 [TBL] [Abstract][Full Text] [Related]
37. Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer. AlHilli MM; Podratz KC; Dowdy SC; Bakkum-Gamez JN; Weaver AL; McGree ME; Keeney GL; Cliby WA; Mariani A Gynecol Oncol; 2013 Oct; 131(1):103-8. PubMed ID: 23845691 [TBL] [Abstract][Full Text] [Related]
38. MELF Pattern for Predicting Lymph Node Involvement and Survival in Grade I-II Endometrioid-type Endometrial Cancer. Sanci M; Güngördük K; Gülseren V; Karadeniz T; Kocaer M; Gungorduk O; Özdemir İA Int J Gynecol Pathol; 2018 Jan; 37(1):17-21. PubMed ID: 28319574 [TBL] [Abstract][Full Text] [Related]
39. How deep is too deep? Assessing myometrial invasion as a predictor of distant recurrence in stage I endometrioid endometrial cancer. Dinoi G; Garzon S; Weaver A; McGree M; Glaser G; Langstraat C; Kumar A; Weroha J; Garda AE; Shahi M; Palmieri E; Scambia G; Fanfani F; Mariani A Int J Gynecol Cancer; 2024 Sep; 34(9):1389-1398. PubMed ID: 38821549 [TBL] [Abstract][Full Text] [Related]
40. Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma. Veade AE; Foote J; Ehrisman J; Broadwater G; Davidson BA; Lee PS; Secord AA; Berchuck A; Havrilesky LJ World J Surg Oncol; 2019 May; 17(1):80. PubMed ID: 31077193 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]